Rossari Biotech Ltd (NSE:ROSSARI)
₹ 508.9 -5.05 (-0.98%) Market Cap: 28.25 Bil Enterprise Value: 31.48 Bil PE Ratio: 18.67 PB Ratio: 2.11 GF Score: 84/100

Q3 2026 Rossari Biotech Ltd Earnings Call Transcript

Jan 19, 2026 / 10:30 AM GMT
Release Date Price: ₹521.55 (-2.47%)

Key Points

Positve
  • Rossari Biotech Ltd (BOM:543213) reported a 13% year-on-year revenue growth in Q3 FY26, despite a challenging domestic demand environment.
  • The company's diversified business model and strong customer relationships have helped sustain growth momentum across all business segments.
  • The newly commissioned 15,000 metric tons per annum oscillation facility at UNIO is witnessing a steady ramp-up in utilization.
  • The board has approved the setup of a Greenfield Specialty chemicals manufacturing facility in Saudi Arabia, aiming to enhance supply chain resilience and support international growth.
  • The animal health and nutrition business reported a strong growth of 39% year-on-year, driven by improved traction across key end-user markets.
Negative
  • Profitability was impacted by ongoing investments in capacity expansion, product development, and higher employee-related costs due to new labor codes.
  • The institutional and B2C businesses continue to operate in a challenging environment, with growth remaining muted.
  • There is a near-term constraint on the availability of ethylene oxide, affecting production.
  • The company's ROC has decreased to sub-15%, indicating a need for improved profitability.
  • The B2C segment is underperforming, pulling down overall profitability, leading to a reassessment of this business vertical.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ROSB.NS - Rossari Biotech Ltd
Q3 2026 Rossari Biotech Ltd Earnings Call
Jan 19, 2026 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Rosari Biotech Limited earnings conference call.

As a reminder, all participant lines will remain in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal the operator by pressing, then 0 on your touchstone telephone.

Please note that this conference is being recorded.

I will now have the conference over to Mr. Mash Jain from CDR India for opening remarks.

Thank you and over to you, Mash.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot